# US 2020/0369665 A1 · Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0369665 A1
- Document ID: US20200369665A1
- Status: Published application
- Kind: A1
- Application number: 16/624,071
- Filed: 2018-06-29
- Published: 2020-11-26
- Earliest claimed: 2017-06-30
- Assignees: Ryvu Therapeutics S.A.
- Applicants: Ryvu Therapeutics S.A.
- Inventors: Aneta BOBOWSKA (NÉE WITKOWSKA); Michal GALEZOWSKI; Mateusz NOWAK; Claude COMMANDEUR; Joanna SZEREMETA-SPISAK; Marcin NOWOGRODZKI; Alicja OBARA; Anna DZIELAK; Iwona LOZINSKA; Marcelina DUDEK (NÉE SEDLAK); Anita ` JANIGA; Jacek REUS; Marek WRONOWSKI; Magdalena ZASTAWNA; Adam RADZIMIERSKI; Mateusz SWIRSKI; Julian ZACHMANN; Charles-Henry FABRITIUS; Roderick Alan PORTER; Joanna FOGT
- Web page: https://patentgrep.com/patent/US20200369665A1

## CPC

- C07D 487/04: Ortho-condensed systems
- A61K 31/4985: Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to the compound of formula (I) and salts, stereoisomers, tautomers, isotopologues, or N-oxides thereof. The present invention is further concerned with the use of such a compound or salt, stereoisomer, tautomer, isotopologues, or N-oxide thereof as medicament and a pharmaceutical composition comprising said compound.

## Claims

### Claim 1

A compound of formula (I):
or a salt, stereoisomer, tautomer, isotopologue, or N-oxide thereof,
wherein
R1 is selected from the group consisting of a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R6;
R2 is NH2;
R3 is selected from the group consisting of
(i) H, halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R8;
(ii) C(═O)R25, C(═O)OR26, C(═O)SR26, C(═O)N(R26a)(R26b), OR26, S(═O)nR26, S(═O)nN(R26a)(R26b), S(═O)mOR26, N(R26a)(R26b), N(R26)C(═O)R25, N(R26)C(═O)OR26, N(R26)C(═O)N(R26a)(R26b), N(R26)S(═O)n(R26), N(R26)S(═O)mN(R26a)(R26b), and N(R26)S(═O)mOR26;
R4 is H;
R5 is selected from the group consisting of a 5- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 9- to 12-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R17;
R6 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R7;
(ii) C(═O)R11, C(═O)OR12, C(═O)SR12, C(═O)N(R12a)(R12b), OR12, S(═O)nR12, S(═O)nN(R12a)(R12b), S(═O)mOR12, N(R12a)(R12b), N(R12)C(═O)R11, N(R12)C(═O)OR12, N(R12)C(═O)N(R12a)(R12b), N(R12)S(═O)n(R12), N(R12)S(═O)mN(R12a)(R12b), and N(R12)S(═O)mOR12;
and/or two R6 present on one C-atom together form ═O;
R7 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R10;
(ii) C(═O)R21, C(═O)OR22, C(═O)SR22, C(═O)N(R22a)(R22b), OR22, S(═O)nR22, S(═O)nN(R22a)(R22b), S(═O)mOR22, N(R22a)(R22b), N(R22)C(═O)R21, N(R22)C(═O)OR22, N(R22)C(═O)N(R22a)(R22b), N(R22)S(═O)n(R22), N(R22)S(═O)mN(R22a)(R22b), and N(R22)S(═O)mOR22;
R8 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R9;
(ii) C(═O)R27, C(═O)OR28, C(═O)SR28, C(═O)N(R28a)(R28b), OR28, S(═O)nR28, S(═O)nN(R28a)(R28b), S(═O)mOR28, N(R28a)(R28b), N(R28)C(═O)R27, N(R28)C(═O)OR28, N(R28)C(═O)N(R28a)(R28b), N(R28)S(═O)n(R28), N(R28)S(═O)mN(R28a)(R28b), and N(R28)S(═O)mOR2;
R9 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R29;
(ii) C(═O)R30, C(═O)OR31, C(═O)SR31, C(═O)N(R31a)(R31b), OR31, S(═O)nR31, S(═O)nN(R31a)(R31b) S(═O)mOR31, N(R31a)(R31b) N(R31)C(═O)R30, N(R31)C(═O)OR31, N(R31)C(═O)N(R31a)(R31b) N(R31)S(═O)n(R31), N(R31)S(═O)mN(R31a)(R31b) and N(R31)S(═O)mOR31;
R10 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C(═O)R11, C(═O)OR12, C(═O)SR12, C(═O)N(R12a)(R12b), OR12, S(═O)nR12, S(═O)nN(R12a)(R12b), S(═O)mOR12, N(R12a)(R12b), N(R12)C(═O)R11, N(R12)C(═O)OR12, N(R12)C(═O)N(R12a)(R12b), N(R12)S(═O)n(R12), N(R12)S(═O)mN(R12a)(R12b), and N(R12)S(═O)mOR12;
R11, R12, R12a, and R12b are independently selected from the group consisting of
(i) H, C1-C6-alkyl, C2-C6-alkenyl, and C2-C6-alkynyl, wherein each substitutable carbon atom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R13;
(ii) a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R14;
R13 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, N(R15a)(R15b), C(═O)NR15aR15b, S(═O)nNR15aR15b, OR15 and S(═O)nR15;
(ii) a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R14;
R14 is selected from the group consisting of halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C(═O)R16, C(═O)OR15, C(═O)SR15, C(═O)N(R15a)(R15b), OR15, S(═O)nR15, S(═O)nN(R15a)(R15b), S(═O)mOR15, N(R15a)(R15b), N(R15)C(═O)R16, N(R15)C(═O)OR15, N(R15)C(═O)N(R15a)(R15b), N(R15)S(═O)n(R15), N(R15)S(═O)mN(R15a)(R15b), and N(R15)S(═O)mOR15;
R15, R15a, R15b, and R16 are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
R17 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, and a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R11;
(ii) C(═O)R19, C(═O)OR2, C(═O)SR20, C(═O)N(R26a)(R20b), OR20, S(═O)nR20, S(═O)nN(R20a)(R20b), S(═O)mOR20, N(R20a)(R20b), N(R20)C(═O)R19, N(R20)C(═O)OR20, N(R20)C(═O)N(R20a)(R20b), N(R20)S(═O)n(R20), N(R20)S(═O)mN(R20a)(R20b), and N(R20)S(═O)mOR20;
and/or two R17 present on one C-atom together form ═O;
R18 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
(ii) C(═O)R23, C(═O)OR24, C(═O)SR24, C(═O)N(R24a)(R24b), OR24, S(═O)nR24, S(═O)nN(R24a)(R24b), S(═O)mOR24, N(R24a)(R24b), N(R24)C(═O)R23, N(R24)C(═O)OR24, N(R24)C(═O)N(R24a)(R24b), N(R24)S(═O)n(R24), N(R24)S(═O)mN(R24a)(R24b), and N(R24)S(═O)mOR24;
R19, R20, R20a, and R20b are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
R21, R22, R22a, and R22b are independently selected from the group consisting of
(i) H, C1-C6-alkyl, C2-C6-alkenyl, and C2-C6-alkynyl, wherein each substitutable carbon atom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R13;
(ii) a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R14;
R23, R24, R24a, and R24b are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
R25, R26, R26a, and R26b are independently selected from the group consisting of H, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R32;
R27, R28, R28a, and R28b are independently selected from the group consisting of H, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R33;
R29 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C(═O)R34, C(═O)OR35, C(═O)SR35, C(═O)N(R35a)(R35b), OR35, S(═O)nR35, S(═O)nN(R35a)(R35b), S(═O)mOR35, N(R35a)(R35b), N(R35)C(═O)R34, N(R35)C(═O)OR35, N(R35)C(═O)N(R35a)(R35b), N(R35)S(═O)n(R35), N(R35)S(═O)mN(R35a)(R35b), and N(R35)S(═O)mOR35;
R30, R31, R31a, and R31b are independently selected from the group consisting of H, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R37;
R32 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R38;
(ii) C(═O)R39, C(═O)OR40, C(═O)SR40, C(═O)N(R40a)(R40b), OR40, S(═O)nR40, S(═O)nN(R40a)(R40b), S(═O)mOR40, N(R40a)(R40b), N(R40)C(═O)R39, N(R40)C(═O)OR40, N(R40)C(═O)N(R40a)(R40b), N(R40)S(═O)n(R40), N(R40)S(═O)mN(R40a)(R40b), and N(R40)S(═O)mOR40;
R33 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R41;
(ii) C(═O)R42, C(═O)OR43, C(═O)SR43, C(═O)N(R43a)(R43b), OR43, S(═O)nR43, S(═O)nN(R43a)(R43b), S(═O)mOR43, N(R43a)(R43b), N(R43)C(═O)R42, N(R43)C(═O)OR43, N(R43)C(═O)N(R43a)(R43b), N(R43)S(═O)n(R43), N(R43)S(═O)mN(R43a)(R43b), and N(R43)S(═O)mOR43;
R34, R35, R35a, and R35b are independently selected from the group consisting of
(i) H, C1-C6-alkyl, C2-C6-alkenyl, and C2-C6-alkynyl, wherein each substitutable carbon atom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R36;
(ii) a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R52;
R36 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, N(R53a)(R53b), C(═O)NR53aR53b, S(═O)nNR53aR53b, OR53 and S(═O)nR53;
(ii) a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R52;
R37 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
R38 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R44;
(ii) C(═O)R45, C(═O)OR46, C(═O)SR46, C(═O)N(R46a)(R46b), OR46, S(═O)nR46, S(═O)nN(R46a)(R46b), S(═O)mOR46, N(R46a)(R46b), N(R46)C(═O)R45, N(R46)C(═O)OR46, N(R46)C(═O)N(R46a)(R46b), N(R46)S(═O)n(R46), N(R46)S(═O)mN(R46a)(R46b), and N(R46)S(═O)mOR46;
R39, R40, R40a, and R40b are independently selected from the group consisting of H, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R47;
R41 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
R42, R43, R43a, and R43b are independently selected from the group consisting of H, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R48;
R44 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R49;
R45, R46, R46a, and R46b are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
R47 is selected from the group consisting of halogen, CN, NO2, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl), C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R11;
R48 is selected from the group consisting of halogen, CN, NO2, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl), C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or hetero-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R51;
R49, R50, and R51 are independently selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
R52 is selected from the group consisting of halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C(═O)R54, C(═O)OR53, C(═O)SR53, C(═O)N(R53a)(R53b), OR53, S(═O)nR53, S(═O)nN(R53a)(R53b), S(═O)mOR53, N(R53a)(R53b), N(R53)C(═O)R54, N(R53)C(═O)OR53, N(R53)C(═O)N(R53a)(R53b), N(R53)S(═O)n(R53), N(R53)S(═O)mN(R53a)(R53b), and N(R53)S(═O)mOR53;
R53, R53a, R53b, and R54 are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
and wherein
n is 0, 1 or 2; and
m is for 2.

### Claim 2 (depends on 1)

The compound according to claim 1, wherein R1 is selected from the group consisting of a 3- to 9-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 6- to 14-membered saturated, partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R6;
wherein R6 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, and C2-C6-alkynyl, wherein each substitutable carbon-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R7;
(ii) C(═O)R11, C(═O)OR12, C(═O)SR12, C(═O)N(R12a)(R12b), OR12, S(═O)nR12, S(═O)nN(R12a)(R12b), S(═O)mOR12, N(R12a)(R12b), N(R12)C(═O)R11, N(R12)C(═O)OR12, N(R12)C(═O)N(R12a)(R12b), N(R12)S(═O)n(R12), N(R12)S(═O)mN(R12a)(R12b), and N(R12)S(═O)mOR12;
and/or two R6 present on one C-atom together form ═O;
wherein R7 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, and C2-C6-alkynyl,
(ii) C(═O)R21, C(═O)OR22, C(═O)SR22, C(═O)N(R22a)(R22b), OR22, S(═O)nR22, S(═O)nN(R22a)(R22b), S(═O)mOR22, N(R22a)(R22b), N(R22)C(═O)R21, N(R22)C(═O)OR22, N(R22)C(═O)N(R22a)(R22b), N(R22)S(═O)n(R22), N(R22)S(═O)mN(R22a)(R22b), and N(R22)S(═O)mOR22;
wherein R11, R12, R12a, R12b, R21, R22, R22a, and R22b are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
and wherein all other substituents have the meaning as defined in claim 1.

### Claim 3 (depends on 1)

The compound according to claim 1, wherein R1 is selected from the group consisting of a 5- to 6-membered fully unsaturated carbocyclic or heterocyclic ring and a 9- to 10-membered fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R6;
wherein R6 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C3-alkyl, C2-C3-alkenyl, and C2-C3-alkynyl, wherein each substitutable carbon-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R7;
(ii) C(═O)R11, C(═O)OR12, C(═O)N(R12a)(R12b), OR12, N(R12a)(R12b), N(R12)C(═O)R11, N(R12)C(═O)OR12, and N(R12)C(═O)N(R12a)(R12b);
and/or two R6 present on one C-atom together form ═O;
wherein R7 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, and C2-C6-alkynyl,
(ii) C(═O)R21, C(═O)OR22, C(═O)N(R22a)(R22b), OR22, N(R22a)(R22b), N(R22)C(═O)R21, N(R22)C(═O)OR22, and N(R22)C(═O)N(R22a)(R22b);
wherein R11, R12, R12a, R12b, R21, R22, R22a, and R22b are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl; and
wherein all other substituents have the meaning as defined in claim 1.

### Claim 4 (depends on 1)

The compound according to claim 1, wherein R1 is a 5- to 6-membered fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents selected from the group consisting of halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl); and wherein all other substituents have the meaning as defined in claim 1.

### Claim 5 (depends on 1)

The compound according to claim 1, wherein R5 is selected from the group consisting of a 5- to 6-membered partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 9- to 10-membered partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R17, and wherein all other substituents have the meaning as defined in claim 1.

### Claim 6 (depends on 1)

The compound according to claim 1, wherein R5 is selected from the group consisting of a 5- to 6-membered partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 9- to 10-membered partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R17;
wherein R17 is selected from the group consisting of halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, C(═O)R19, C(═O)OR20, C(═O)N(R20a)(R20b), OR20, N(R20a)(R20b), N(R20)C(═O)R19, N(R20)C(═O)OR20, and N(R20)C(═O)N(R20a)(R20b);
and/or two R17 present on one C-atom together form ═O;
wherein R19, R20, R20a, and R20b are independently selected from the group consisting of H, C1-C2-alkyl, and C1-C2-haloalkyl; and
wherein all other substituents have the meaning as defined in claim 1.

### Claim 7 (depends on 1)

The compound according to claim 1, wherein R5 has the formula (S1):
and wherein
A is N or CR5c;
R5a, R5b, and R5c are independently selected from the group consisting of
(i) H, halogen, CN, NO2, C1-C4-alkyl, C2-C4-alkenyl, and C2-C4-alkynyl, wherein each substitutable carbon-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R18;
(ii) C(═O)R19, C(═O)OR2, C(═O)SR20, C(═O)N(R20a)(R20b), OR20, S(═O)nR20, S(═O)nN(R20a)(R20b), S(═O)mOR20, N(R20a)(R20b), N(R20)C(═O)R19, N(R20)C(═O)OR20, N(R20)C(═O)N(R20a)(R20b), N(R20)S(═O)n(R20), N(R20)S(═O)mN(R20a)(R20b), and N(R20)S(═O)mOR20;
with the proviso that at least one of R5a, R5b, R5c is not H;
or
R5a is selected from the group consisting of
(i) H, halogen, CN, NO2, C1-C4-alkyl, C2-C4-alkenyl, and C2-C4-alkynyl, wherein each substitutable carbon-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R18;
(ii) C(═O)R19, C(═O)OR20, C(═O)SR20, C(═O)N(R20a)(R20b), OR20, S(═O)nR20, S(═O)nN(R20a)(R20b), S(═O)mOR20, N(R20a)(R20b), N(R20)C(═O)R19, N(R20)C(═O)OR20, N(R20)C(═O)N(R20a)(R20b), N(R20)S(═O)n(R20), N(R20)S(═O)mN(R20a)(R20b), and N(R20)S(═O)mOR20;
and
R5b and R5c together with the atoms to which they are attached form a 5- to 6-membered partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents selected from the group consisting of
(i) H, halogen, CN, NO2, C1-C4-alkyl, C2-C4-alkenyl, and C2-C4-alkynyl, wherein each substitutable carbon-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R18;
(ii) C(═O)R19, C(═O)OR2, C(═O)SR20, C(═O)N(R20a)(R20b), OR20, S(═O)nR20, S(═O)nN(R20a)(R20b), S(═O)mOR20, N(R20a)(R20b), N(R20)C(═O)R19, N(R20)C(═O)OR20, N(R20)C(═O)N(R20a)(R20b), N(R20)S(═O)n(R20), N(R20)S(═O)mN(R20a)(R20b), and N(R20)S(═O)mOR20;
and wherein all other substituents have the meaning as defined in claim 1.

### Claim 8 (depends on 1)

The compound according to claim 1, wherein R5 is selected from the group consisting of a 6-membered fully unsaturated carbocyclic or heterocyclic ring and a 9- to 10-membered fully unsaturated heterobicyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic moieties is independently substituted with one or more, same or different substituents selected from the group consisting of halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl, C(═O)R19, C(═O)OR20, C(═O)N(R20a)(R20b), OR20, N(R20a)(R20b), N(R20)C(═O)R19, N(R20)C(═O)OR20, and N(R20)C(═O)N(R20a)(R20b); and wherein each substitutable carbon or heteroatom in the aforementioned bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents selected from the group consisting of halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl, C(═O)R19, C(═O)OR20, C(═O)N(R20a)(R20b), OR20, N(R20a)(R20b), N(R20)C(═O)R19, N(R20)C(═O)OR20, and N(R20)C(═O)N(R20a)(R20b);
wherein R19, R20, R20a, and R20b are independently selected from the group consisting of H, C1-C2-alkyl, and C1-C2-haloalkyl,
and wherein all other substituents have the meaning as defined in claim 1.

### Claim 9 (depends on 1)

The compound according to claim 1, wherein R3 is selected from the group consisting of
(i) H, C1-C6-alkyl, a 3- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R8;
(ii) C(═O)R25, C(═O)OR26, C(═O)N(R26a)(R26b), OR26, N(R26a)(R26b), N(R26)C(═O)R25, N(R26)C(═O)OR26, and N(R26)C(═O)N(R26a)(R26b);
wherein R8 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R9;
(ii) C(═O)R27, C(═O)OR28, C(═O)N(R28a)(R28b), OR28, N(R28a)(R28b), N(R28)C(═O)R27, N(R28)C(═O)OR28, and N(R28)C(═O)N(R28a)(R28b);
wherein R9 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R29;
(ii) C(═O)R30, C(═O)OR31, C(═O)N(R31a)(R31b) OR31, N(R31a)(R31b), N(R31)C(═O)R30, N(R31)C(═O)OR31, N(R31)C(═O)N(R31a)(R31b);
wherein R25, R26, R26a, and R26b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R32;
wherein R27, R28, R28a, and R28b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R33;
wherein R29 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
wherein R30, R31, R31a, and R31b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R37;
wherein R32 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R38;
(ii) C(═O)R39, C(═O)OR40, C(═O)N(R40a)(R40b), OR40, N(R40a)(R40b), N(R40)C(═O)R39, N(R40)C(═O)OR40, N(R40)C(═O)N(R40a)(R40b);
wherein R33 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R41;
(ii) C(═O)R42, C(═O)OR43, C(═O)N(R43a)(R43b), OR43, N(R43a)(R43b), N(R43)C(═O)R42, N(R43)C(═O)OR43, N(R43)C(═O)N(R43a)(R43b);
wherein R37 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
wherein R38 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R44;
(ii) C(═O)R45, C(═O)OR46, C(═O)N(R46a)(R46b), OR46, N(R46a)(R46b), N(R46)C(═O)R45, N(R46)C(═O)OR46, N(R46)C(═O)N(R46a)(R46b);
wherein R39, R40, R40a, and R40b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R47;
wherein R41 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
wherein R42, R43, R43a, and R43b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R48;
wherein R44 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R4;
wherein R45, R46, R46a, and R46b are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
wherein R47 is selected from the group consisting of halogen, CN, NO2, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl), C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R11;
wherein R48 is selected from the group consisting of halogen, CN, NO2, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl), C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R51;
wherein R49, R50, and R51 are independently selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
and wherein all other substituents have the meaning as defined in claim 1.

### Claim 10 (depends on 1, 9)

The compound according to claim 9, wherein R3 is selected from the group consisting of
(i) (L1)y-X1,
(ii) (L1)y-X1-(L2)y-X2, and
(iii) (L1)y-X1-(L2)y-X2-(L3)y-X3; and
(iv) (L1)y-X1-(L2)y-X2-(L3)y-X3-(L4)y-X4
wherein X1, X2, X3, and X4 are independently selected from the group consisting of H, C1-C6-alkyl, a 3- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
wherein L1, L2, L3, and L4 are independently selected from the group consisting of C(═O), C(═O)O, C(═O)N(Ra), O, N(Ra), N(Ra)C(═O),
wherein Ra is selected from the group consisting of H, C1-C4-alkyl, and C1-C4-haloalkyl, wherein y is 0 or 1,
and wherein all other substituents have the meaning as defined in claim 1.

### Claim 11 (depends on 1)

The compound according to claim 1, wherein R1 is selected from the group consisting of a 5- to 6-membered fully unsaturated carbocyclic or heterocyclic ring and a 9- to 10-membered fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic or heterobicyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R6;
wherein R6 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C3-alkyl, C2-C3-alkenyl, and C2-C3-alkynyl, wherein each substitutable carbon-atom in the aforementioned moieties is unsubstituted or substituted with one or more, same or different substituents R7;
(ii) C(═O)R11, C(═O)OR12, C(═O)N(R12a)(R12b), OR12, N(R12a)(R12b), N(R12)C(═O)R11, N(R12)C(═O)OR12, and N(R12)C(═O)N(R12a)(R12b);
and/or two R6 present on one C-atom together form ═O;
wherein R7 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, C2-C6-alkenyl, and C2-C6-alkynyl,
(ii) C(═O)R21, C(═O)OR22, C(═O)N(R22a)(R22b), OR22, N(R22a)(R22b), N(R22)C(═O)R21, N(R22)C(═O)OR22, and N(R22)C(═O)N(R22a)(R22b);
wherein R11, R12, R12a, R12b, R21, R22, R22a, and R22b are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
wherein R3 is selected from the group consisting of
(i) H, C1-C6-alkyl, a 3- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R8;
(ii) C(═O)R25, C(═O)OR26, C(═O)N(R26a)(R26b), OR26, N(R26a)(R26b), N(R26)C(═O)R25, N(R26)C(═O)OR26, and N(R26)C(═O)N(R26a)(R26b);
wherein R8 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R9;
(ii) C(═O)R27, C(═O)OR28, C(═O)N(R28a)(R28b), OR28, N(R28a)(R28b), N(R28)C(═O)R27, N(R28)C(═O)OR28, and N(R28)C(═O)N(R28a)(R28b);
wherein R9 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R29;
(ii) C(═O)R30, C(═O)OR31, C(═O)N(R31a)(R31b) OR31, N(R31a)(R31b), N(R31)C(═O)R30, N(R31)C(═O)OR31, N(R31)C(═O)N(R31a)(R31b);
wherein R25, R26, R26a, and R26b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R32;
wherein R27, R28, R28a, and R28b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R33;
wherein R29 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
wherein R30, R31, R31a, and R31b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R37;
wherein R32 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R38;
(ii) C(═O)R39, C(═O)OR40, C(═O)N(R40a)(R40b), OR40, N(R40a)(R40b), N(R40)C(═O)R39, N(R40)C(═O)OR40, N(R40)C(═O)N(R40a)(R40b);
wherein R33 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R41;
(ii) C(═O)R42, C(═O)OR43, C(═O)N(R43a)(R43b), OR43, N(R43a)(R43b), N(R43)C(═O)R42, N(R43)C(═O)OR43, N(R43)C(═O)N(R43a)(R43b);
wherein R37 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
wherein R38 is selected from the group consisting of
(i) halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R44;
(ii) C(═O)R45, C(═O)OR46, C(═O)N(R46a)(R46b), OR46, N(R46a)(R46b), N(R46)C(═O)R45, N(R46)C(═O)OR46, N(R46)C(═O)N(R46a)(R46b);
wherein R39, R40, R40a, and R40b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R47;
wherein R41 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
wherein R42, R43, R43a, and R43b are independently selected from the group consisting of H, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R48;
wherein R44 is selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R4;
wherein R45, R46, R46a, and R46b are independently selected from the group consisting of H, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and C2-C4-haloalkynyl;
wherein R47 is selected from the group consisting of halogen, CN, NO2, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl), C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R11;
wherein R48 is selected from the group consisting of halogen, CN, NO2, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl), C1-C6-alkyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned moieties is independently unsubstituted or substituted with one or more, same or different substituents R51;
wherein R49, R50, and R51 are independently selected from the group consisting of halogen, CN, NO2, C1-C6-alkyl, C1-C6-haloalkyl, OH, O(C1-C4-alkyl), NH2, NH(C1-C4-alkyl), and N(C1-C4-alkyl)(C1-C4-alkyl);
wherein R5 is selected from the group consisting of a 5- to 6-membered partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring and a 9- to 10-membered partially unsaturated or fully unsaturated carbobicyclic or heterobicyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, and wherein each substitutable carbon or heteroatom in the aforementioned cyclic or bicyclic moieties is independently unsubstituted or substituted with one or more, same or different substituents R17;
wherein R17 is selected from the group consisting of halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated carbocyclic or heterocyclic ring, wherein said heterocyclic ring comprises one or more, same or different heteroatoms selected from O, N or S, wherein said N- and/or S-atoms are independently oxidized or non-oxidized, C(═O)R19, C(═O)OR2, C(═O)N(R20a)(R20b), OR20, N(R20a)(R20b), N(R20)C(═O)R19, N(R20)C(═O)OR20, and N(R20)C(═O)N(R20a)(R20b);
and/or two R17 present on one C-atom together form ═O;
wherein R19, R20, R20a, and R20b are independently selected from the group consisting of H, C1-C2-alkyl, and C1-C2-haloalkyl;
and wherein all other substituents have the meaning as defined in claim 1.

### Claim 12 (depends on 1)

The compound according to claim 1, wherein said compound is selected from the group consisting 4-{8-amino-6-phenylimidazo[1,2-a]pyrazin-5-yl}-2-chlorophenol; 4-[8-amino-6-(furan-2-yl)imidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 5-(2,6-dimethylpyridin-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine; 5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]-6-phenylimidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 6-(4-fluorophenyl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazin-8-amine; 5-(2,6-dimethylpyridin-4-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazin-8-amine; 3-{8-amino-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazin-6-yl}benzonitrile; 3-[8-amino-5-(3-chloro-4-hydroxyphenyl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 4-[8-amino-2-(3-nitrophenyl)-6-phenylimidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 5-(1H-indazol-5-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine; 4-{8-amino-6-phenylimidazo[1,2-a]pyrazin-5-yl}-2,6-dichlorophenol; 4-{8-amino-2-cyclohexyl-6-phenylimidazo[1,2-a]pyrazin-5-yl}-2-chlorophenol; 4-{8-amino-6-phenylimidazo[1,2-a]pyrazin-5-yl}-2-bromo-6-chlorophenol; 4-{8-amino-6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazin-5-yl}-2-chlorophenol; 3-[8-amino-5-(3-chloro-4-hydroxyphenyl)-6-phenylimidazo[1,2-a]pyrazin-2-yl]benzonitrile; 4-[8-amino-5-(3-chloro-4-hydroxyphenyl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 4-{8-amino-6-phenylimidazo[1,2-a]pyrazin-5-yl}-N-methylpyridin-2-amine; 4-{8-amino-2,6-diphenylimidazo[1,2-a]pyrazin-5-yl}-2-chlorophenol; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]phenol; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-N-methylpyridin-2-amine; 8-amino-5-(3-chloro-4-hydroxyphenyl)-6-phenylimidazo[1,2-a]pyrazine-2-carboxamide; 4-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-N-methylpyridin-2-amine; 6-(3-fluorophenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(3,5-dichlorophenyl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(2-fluorophenyl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazin-8-amine; 3-[8-amino-5-(3,5-dichlorophenyl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 5-(3,5-dichlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-8-amine; 4-{8-amino-6-[3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazin-5-yl}-2-chlorophenol; 5-(3-chloro-1H-indazol-5-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine; 5-(2-chloro-6-methylpyridin-4-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 5-(2-chloro-6-methylpyridin-4-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]benzamide; 5-(3-methyl-1H-indazol-5-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine; 5-(1H-indol-5-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(pyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(1-methyl-1H-pyrazol-3-yl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazin-8-amine; 5-(3-fluoro-1H-indazol-5-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(1-methyl-1H-pyrazol-3-yl)imidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 5-(1-benzofuran-5-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(2-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 6-(3-fluorophenyl)-5-(2-methoxypyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(2-fluoro-6-methylpyridin-4-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 4-{8-amino-2-methyl-6-phenylimidazo[1,2-a]pyrazin-5-yl}-2-chlorophenol; 4-{8-amino-6-phenylimidazo[1,2-a]pyrazin-5-yl}-6-fluoro-N-methylpyridin-2-amine; 3-{8-amino-5-[2-(methylamino)pyridin-4-yl]imidazo[1,2-a]pyrazin-6-yl}benzonitrile; 5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]-6-(naphthalen-2-yl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-5-(3-chloro-4-hydroxyphenyl)-6-phenylimidazo[1,2-a]pyrazin-2-yl]benzonitrile; 5-(2,6-dimethylpyridin-4-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2-chloro-6-methylphenol; 4-[8-amino-6-(3,5-difluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2,6-dichlorophenol; 5-(1,3-benzothiazol-5-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2,6-dimethoxyphenol; 4-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-N,N,6-trimethylpyridin-2-amine; 4-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-N,6-dimethylpyridin-2-amine; 6-(3-fluorophenyl)-5-(1-methyl-1H-indazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(1,3-benzothiazol-6-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 5,6-bis(1,3-benzothiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(7-methyl-1H-indazol-5-yl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(3-fluoro-5-methoxyphenyl)imidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2,6-difluorophenol; ethyl 8-amino-6-(3-fluorophenyl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazine-2-carboxylate; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2-chloro-6-methoxyphenol; 8-amino-6-(3-fluorophenyl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazine-2-carboxamide; 6-(3-fluorophenyl)-5-(2-methylpyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine; 8-amino-5-(3-chloro-4-hydroxyphenyl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazine-2-carboxylic acid; 5-(2,6-dichloropyridin-4-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-N,6-dimethylpyridin-2-amine; 6-(3-fluorophenyl)-5-{imidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2,6-dimethylphenol; 8-amino-6-(3-fluorophenyl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazine-2-carboxylic acid; 8-amino-6-(3-fluorophenyl)-N,N-dimethyl-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(3-fluorophenyl)-N-methyl-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazine-2-carboxamide; 5-(4-amino-3,5-dichlorophenyl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(isoquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(2-methoxy-6-methylpyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(1H-1,3-benzodiazol-6-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(1-methyl-H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; ethyl 8-amino-5-(3-chloro-4-hydroxyphenyl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazine-2-carboxylate; 4-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-6-methyl-N-(propan-2-yl)pyridin-2-amine; 6-(3-fluorophenyl)-5-(4-methyl-1,3-benzothiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 8-amino-6-(3-fluorophenyl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]-N-(oxolan-3-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 5-(8-chloroquinolin-6-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(3-fluorophenyl)-2-(4-methylpiperazine-1-carbonyl)imidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1-methyl-2,3-dihydro-1H-1,3-benzodiazol-2-one; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2,3-dihydro-1H-indol-2-one; 6-(3-fluorophenyl)-5-(quinoxalin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(2-chloropyridin-4-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 5-(4-fluoro-1,3-benzothiazol-6-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-3-bromopyridin-2-ol; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1,2-dihydropyridin-2-one; 8-amino-5-(3-chloro-4-hydroxyphenyl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazine-2-carboxamide; 6-(3-fluorophenyl)-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]-2-phenylimidazo[1,2-a]pyrazin-8-amine; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1,3-dimethyl-1,2-dihydropyridin-2-one; 6-(3-fluorophenyl)-5-[2-(pyrrolidin-1-yl)pyridin-4-yl]imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-2-(aminomethyl)-6-phenylimidazo[1,2-a]pyrazin-5-yl]-2-chlorophenol; 6-(3-fluorophenyl)-5-{pyrazolo[1,5-a]pyrimidin-6-yl}imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(8-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(1-methyl-1H-1,2,3-benzotriazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1,3-benzothiazol-2-amine; 6-(3-fluorophenyl)-5-(8-fluoroquinoxalin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-{8-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-8-amine; 3-[8-amino-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; N-{4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-6-methylpyridin-2-yl}acetamide; 6-(3-fluorophenyl)-5-[8-(trifluoromethyl)quinolin-6-yl]imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(8-methoxyquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(1,8-naphthyridin-3-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(7-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(4-fluoro-1-methyl-1H-1,3-benzodiazol-6-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(1,8-naphthyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine; ethyl 8-amino-6-(3-fluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxylate; [8-amino-6-(3-fluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-2-yl]methanol; 6-(3-fluorophenyl)-5-[2-methyl-6-(pyrrolidin-1-yl)pyridin-4-yl]imidazo[1,2-a]pyrazin-8-amine; 5-{8-fluoroimidazo[1,2-a]pyridin-6-yl}-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 2-[8-amino-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]phenol; 6-(6-fluoropyridin-2-yl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1-ethyl-1,2-dihydropyridin-2-one; 6-(3-fluorophenyl)-5-{1H-pyrrolo[2,3-b]pyridin-3-yl}imidazo[1,2-a]pyrazin-8-amine; 5-(5,8-difluoroquinolin-6-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]quinolin-8-amine; ethyl 2-[8-amino-6-(3-fluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-2-yl]acetate; 5-(7-fluoro-1H-indazol-5-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]quinoline-8-carbonitrile; 5-{8-fluoro-[1,2,4]triazolo[1,5-a]pyridin-6-yl}-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 5-(4-fluoro-1H-1,3-benzodiazol-6-yl)-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2-fluoro-6-(trifluoromethyl)phenol; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]isoquinolin-1-ol; 2-[8-amino-6-(3-fluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-2-yl]acetic acid; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2,3-dihydro-1H-isoindol-1-one; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-2,3-dihydro-1H-inden-1-one; 2-[8-amino-6-(3-fluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-2-yl]ethan-1-ol; 2-[8-amino-6-(3-fluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-2-yl]acetamide; 6-(3-fluorophenyl)-5-(4-methoxy-1,3-benzothiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]naphthalen-1-ol; 5-[4-fluoro-1-(propan-2-yl)-1H-1,3-benzodiazol-6-yl]-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(3-methyl-1H-indazol-5-yl)imidazo[1,2-a]pyrazin-8-amine; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1-ethyl-3-fluoro-1,2-dihydropyridin-2-one; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]quinolin-3-amine; 5-(4-fluoro-1,3-benzothiazol-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 3-[8-amino-5-(4-fluoro-1,3-benzothiazol-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 6-(4-fluorophenyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(1,3-benzothiazol-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(quinazolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(8-chloroquinolin-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 5-(8-fluoro-4-methylquinolin-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(1-methyl-H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(4-fluoro-1-methyl-1H-1,3-benzodiazol-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-{3-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-8-amine; 3-(8-amino-5-{8-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-6-yl)benzonitrile; 3-[8-amino-5-(8-chloroquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 3-[8-amino-5-(1,3-benzothiazol-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 6-(3-fluorophenyl)-5-[5-(1H-pyrazol-5-yl)thiophen-2-yl]imidazo[1,2-a]pyrazin-8-amine; 3-[8-amino-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 3-[8-amino-5-(8-methoxyquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 3-[8-amino-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-N-methylquinolin-8-amine; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-N,N-dimethylquinolin-8-amine; 5-(4-chloro-1,3-benzothiazol-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 8-amino-6-(3-cyanophenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 2-[8-amino-6-(3-cyanophenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-2-yl]acetamide; 6-(4-fluorophenyl)-5-(2-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 3-[8-amino-5-(8-aminoquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 6-(4-fluorophenyl)-5-(3-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(3,5-dichloro-4-methoxyphenyl)-6-phenylimidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(2-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; methyl 5-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]furan-2-carboxylate; 5-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1,2-dihydropyridin-2-one; 3-[8-amino-5-(3-aminoquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 3-(8-amino-5-{3-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-6-yl)benzonitrile; 3-[8-amino-5-(5-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 6-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]imidazo[1,2-a]pyridine-3-carbonitrile; 5-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1-methyl-1,2-dihydropyridin-2-one; 5-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1-methyl-,2-dihydropyridin-2-one; 6-[8-amino-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]imidazo[1,2-a]pyridine-3-carbonitrile; 5-(4,8-dimethylquinolin-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 5-(1H-1,3-benzodiazol-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-{3-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(4-methoxy-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(3-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-1-(difluoromethyl)-1,2-dihydropyridin-2-one; 1-{4-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]pyridin-2-yl}ethan-1-one; 5-{8-fluoro-3-methylimidazo[1,2-a]pyridin-6-yl}-6-(3-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 4-{8-amino-2-cyclopropyl-6-phenylimidazo[1,2-a]pyrazin-5-yl}-2-chlorophenol; 6-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]quinolin-3-amine; 6-(4-fluorophenyl)-5-{2-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-{imidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(3-fluoropyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(3-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 3-(8-amino-5-{imidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-6-yl)benzonitrile; 5-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-3-methyl-1,2-dihydropyridin-2-one; 3-[8-amino-5-(1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 6-(4-fluorophenyl)-5-{[1,2,4]triazolo[4,3-a]pyridin-6-yl}imidazo[1,2-a]pyrazin-8-amine; 5-{3-ethylimidazo[1,2-a]pyridin-6-yl}-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-{pyrazolo[1,5-a]pyridin-5-yl}imidazo[1,2-a]pyrazin-8-amine; 5-[8-amino-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-5-yl]-3-fluoro-1,2-dihydropyridin-2-one; 4-{8-amino-5-[2-methyl-6-(trifluoromethyl)pyridin-4-yl]imidazo[1,2-a]pyrazin-6-yl}benzonitrile; 4-[8-amino-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 6-(3-fluorophenyl)-5-{1H,2H,3H-pyrrolo[2,3-b]pyridin-4-yl}imidazo[1,2-a]pyrazin-8-amine; 5-(8-fluoroquinolin-6-yl)-6-(pyridin-3-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(2-fluoropyridin-4-yl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-[8-amino-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-6-yl]-2-fluorobenzonitrile; 5-[8-amino-6-(5-methylfuran-2-yl)imidazo[1,2-a]pyrazin-5-yl]-1,2-dihydropyridin-2-one; 5-[8-amino-6-(1-methyl-1H-pyrazol-3-yl)imidazo[1,2-a]pyrazin-5-yl]-1,2-dihydropyridin-2-one; 5-[8-amino-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]-2-fluorobenzonitrile; 6-(3-methoxyphenyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(1-methyl-1H-pyrazol-3-yl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]-2-fluorobenzonitrile; 6-(5-methylfuran-2-yl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; {4-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]thiophen-2-yl}methanol; 6-(6-fluoropyridin-2-yl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 1-{4-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]pyridin-2-yl}ethan-1-one; 5-(4-methylquinolin-6-yl)-6-(pyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine; 4-[8-amino-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 4-[8-amino-5-(8-chloroquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 4-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; {5-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]furan-2-yl}methanol; 4-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]pyridine-2-carbonitrile; 5-(quinolin-6-yl)-6-(1,3-thiazol-4-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-aminophenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 2-{4-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]-1H-pyrazol-1-yl}ethan-1-ol; 5-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]pyridine-3-carbonitrile; 5-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]thiophene-2-carbonitrile; 6-(2-methylpyridin-4-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]pyridin-2-amine; 6-(2-methoxypyridin-4-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-methoxyphenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-nitrophenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(6-methoxypyridin-3-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; methyl 5-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]furan-2-carboxylate; 5-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]-3-methylpyridine-2-carbonitrile; 3-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]phenol; 5-(8-fluoroquinolin-6-yl)-6-(furan-2-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-methoxyphenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(6-fluoropyridin-2-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(pyridin-4-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(8-fluoroquinolin-6-yl)-6-(6-methoxypyridin-3-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(6-fluoropyridin-3-yl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(3,4-difluorophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(8-fluoroquinolin-6-yl)-6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazin-8-amine; 6-(furan-2-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(5-methylfuran-2-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(pyridin-3-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(1-methyl-1H-pyrazol-3-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; {3-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]phenyl}methanol; 6-(5-fluoropyridin-3-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(6-fluoropyridin-3-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(quinolin-6-yl)-6-[3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyrazin-8-amine; 6-(3-aminophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 3-[8-amino-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]phenol; 6-(1,3-benzothiazol-6-yl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(8-fluoroquinolin-6-yl)-6-(4-methoxyphenyl)imidazo[1,2-a]pyrazin-8-amine; 5-(8-fluoroquinolin-6-yl)-6-(1H-pyrazol-5-yl)imidazo[1,2-a]pyrazin-8-amine; 3-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]benzonitrile; 5-[8-amino-6-(5-methylfuran-2-yl)imidazo[1,2-a]pyrazin-5-yl]-1-ethyl-1,2-dihydropyridin-2-one; 6-(5-chloro-6-methoxypyridin-3-yl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 1-{5-[8-amino-5-(quinolin-6-yl)imidazo[1,2-a]pyrazin-6-yl]pyridin-2-yl}ethan-1-one; 6-(3,4-difluorophenyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(4-methylquinolin-6-yl)-6-(1,3-thiazol-4-yl)imidazo[1,2-a]pyrazin-8-amine; 8-amino-6-(3-fluorophenyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(3-fluorophenyl)-N-methyl-5-{3-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(4-fluorophenyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(3-fluorophenyl)-5-{3-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(4-fluorophenyl)-N-methyl-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(3-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(4-fluorophenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; ethyl 8-amino-6-(4-fluorophenyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxylate; ethyl 8-amino-6-(3-cyanophenyl)-5-(8-fluoroquinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxylate; 6-(4-fluorophenyl)-5-(4-methylquinolin-6-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(quinolin-6-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-amine; 8-amino-6-(4-fluorophenyl)-N-methyl-5-(1-methyl-H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 6-(3-fluorophenyl)-5-(1-methyl-H-1,3-benzodiazol-6-yl)-2-(morpholine-4-carbonyl)imidazo[1,2-a]pyrazin-8-amine; 6-(3-fluorophenyl)-5-(8-fluoroquinolin-6-yl)-2-[4-(4-methoxybenzoyl)piperazine-1-carbonyl]imidazo[1,2-a]pyrazin-8-amine; 2-[4-(2,4-difluorophenyl)piperazine-1-carbonyl]-6-(3-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; ethyl 8-amino-6-(4-fluorophenyl)-5-(quinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxylate; 1-[8-amino-6-(4-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazine-2-carbonyl]-4-methylpiperidin-4-ol; 8-amino-6-(3-fluorophenyl)-N,N-dimethyl-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 6-(4-fluorophenyl)-2-(4-methylpiperazine-1-carbonyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazin-8-amine; 8-amino-6-(4-fluorophenyl)-5-{3-methylimidazo[1,2-a]pyridin-6-yl}imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(4-fluorophenyl)-N-(2-methoxyethyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 8-amino-6-(4-fluorophenyl)-N,N-dimethyl-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 2-[4-(2,4-difluorophenyl)piperazine-1-carbonyl]-6-(4-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 8-amino-N-({1-[(2,4-difluorophenyl)methyl]piperidin-4-yl}methyl)-6-(4-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazine-2-carboxamide; 2-[8-amino-6-(4-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-2-yl]-1-[4-(2,4-difluorophenyl)piperazin-1-yl]ethan-1-one; 6-(4-fluorophenyl)-5-(4-methylquinolin-6-yl)-2-(piperazine-1-carbonyl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluoro-3-methylphenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(6-fluoropyridin-3-yl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 6-(4-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)-2-(4-methylpiperazine-1-carbonyl)imidazo[1,2-a]pyrazin-8-amine; 6-(6-fluoropyridin-2-yl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-8-amine; 2-[8-amino-6-(4-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-2-yl]acetamide; [8-amino-6-(4-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazin-2-yl]methanol; ethyl 8-amino-6-(4-fluorophenyl)-5-(1-methyl-1H-1,3-benzodiazol-6-yl)imidazo[1,2-a]pyrazine-2-carboxylate; 6-(4-fluorophenyl)-5-(4-methylquinolin-6-yl)-2-(morpholine-4-carbonyl)imidazo[1,2-a]pyrazin-8-amine; 5-(1-methyl-1H-1,3-benzodiazol-6-yl)-6-(pyridin-4-yl)imidazo[1,2-a]pyrazin-8-amine; 5-(1-ethyl-1H-1,3-benzodiazol-6-yl)-6-(4-fluorophenyl)imidazo[1,2-a]pyrazin-8-amine; and 1-[8-amino-6-(4-fluorophenyl)-5-(4-methylquinolin-6-yl)imidazo[1,2-a]pyrazine-2-carbonyl]-4-methylpiperidin-4-ol.

### Claim 13 (depends on 1)

A pharmaceutical composition comprising a pharmaceutically effective amount of the compound according to claim 1, or a salt, stereoisomer, tautomer, isotopologue, or N-oxide thereof and a pharmaceutically acceptable carrier, diluent or excipient.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

A method for treating a disease selected from the group consisting of cancer, Parkinson's disease, Huntington's disease, Alzheimer's disease, psychosis, stroke, extra pyramidal syndrome (in particular dystonia, akathisia, pseudoparkinsonism and tardive dyskinesia), attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), amyotrophic lateral sclerosis, cirrhosis, fibrosis, fatty liver, addictive behavior, dermal fibrosis (in particular dermal fibrosis in scleroderma), sleep disorders, AIDS, autoimmune diseases, infections, atherosclerosis and ischemia-reperfusion injury, comprising administering to a patient in need thereof a pharmaceutically effective amount of the compound as defined in claim 1, or a salt, stereoisomer, tautomer, isotopologue, or N-oxide thereof.

### Claim 16 (depends on 1)

A method for treating cancer, comprising administering to a patient in need thereof a pharmaceutically effective amount of the compound as defined in claim 1, or a salt, stereoisomer, tautomer, isotopologue, or N-oxide thereof, wherein at least one further anti-neoplastic agent is coadministered with said compound.

### Claim 17 (depends on 16)

The method according to claim 16, wherein said anti-neoplastic agent is selected from the group consisting of a chemotherapeutic agent, a topoisomerase II inhibitor, an antimetabolite, a topoisomerase I inhibitor, a hormone, a hormonal analogue, a signal transduction pathway inhibitor, a non-receptor tyrosine kinase inhibitor, an angiogenesis inhibitor, a proapoptotic agent, a cell cycle signaling inhibitor, a proteasome inhibitor, an inhibitors of cancer metabolism, and an immunotherapeutic agent.

### Claim 18 (depends on 21)

The method according to claim 21, wherein said checkpoint inhibitor targets PD-1, PD-L1, CTLA-4, IDO, KIR, TIM-3, LAG-3, CD39, CD73, ICOS, OX40, Tim-3, Vista, BTLA, TDO, or TIGIT.

### Claim 19 (depends on 21)

The method according to claim 21, wherein said checkpoint inhibitor is an antibody selected from the group consisting of an anti-PD-1, anti-PD-L1, anti-CTLA-4, anti-IDO, anti-KIR, anti-TIM-3, anti-LAG-3, anti-CD39, anti-CD73, anti-ICOS, anti-OX40, anti-Tim-3, anti-Vista, anti-BTLA, anti-TDO, and anti-TIGIT-antibody.

### Claim 20 (depends on 17)

The method according to claim 17, wherein said chemotherapeutic agent is selected from the group consisting of an anti-microtubule agent, an platinum coordination complex and an antibiotic agent.

### Claim 21 (depends on 17)

The method according to claim 17, wherein said immunotherapeutic agent is selected from the group consisting of a STING pathway modulating compound, a TLR agonist and a checkpoint inhibitor.
